Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 4Squamous Cell Carcinoma of Head and Neck 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Somatostatinoma 1Ovarian Neoplasms 1Neurologic Manifestations 1Neuroendocrine Tumors 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Lung Neoplasms 1Leukemia 1Kidney Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Fallopian Tube Neoplasms 1Brain Neoplasms 1Attention Deficit Disorder with Hyperactivity 1

Interventions

Bevacizumab 4Temozolomide 3Irinotecan 3Sorafenib 2Radiosurgery 2pembrolizumab 1ibrutinib 1Vorinostat 1Valproic Acid 1Transcranial Magnetic Stimulation 1Therapeutics 1Thalidomide 1Surveys and Questionnaires 1Standard of Care 1Sildenafil Citrate 1Radiotherapy 1Pliability 1Plasma Exchange 1Palliative Care 1Nivolumab 1Morphine 1Methadone 1Lenalidomide 1Laparoscopy 1Immunoglobulins 1Exercise 1Equipment and Supplies 1Eating 1Cytidine Triphosphate 1Clomipramine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurologic Manifestations × Cytidine Triphosphate × Clear all
NCT01163526 2017-01-30

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

Stanford University

Terminated
13 enrolled
EndocrineGastrointestinalNET

Colonic Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Neurologic Manifestations, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡